Literature DB >> 10935844

Type II neurofibromatosis presenting as quadriceps atrophy.

L Grazzi1, L Chiapparini, E A Parati, S Giombini, D D'Amico, M Leone, G Bussone.   

Abstract

A young woman aged 26 years presented with atrophy of the left quadriceps progressing over one year. Magnetic resonance imaging (MRI) showed a large lesion of the lumbar plexus compatible with neurinoma. Cerebral MRI revealed a lesion in the right eighth cranial nerve also compatible with neurinoma. On further questioning of the patient, it was learned that her mother had undergone surgery twice for acoustic neurinoma. Type II neurofibromatosis was diagnosed from the basis of clinical picture, neuroimaging findings and family history. This case is unusual for the lack of central nervous system (CNS) symptoms. Expansive radicular lesions compatible with neurinoma should prompt cerebral MRI. Regular examination of family members at risk and early diagnosis can decrease the high mortality associated with this condition.

Entities:  

Mesh:

Year:  1998        PMID: 10935844     DOI: 10.1007/bf02427564

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  11 in total

1.  Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma.

Authors:  B R Seizinger; R L Martuza; J F Gusella
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

Review 2.  National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. The Consensus Development Panel.

Authors: 
Journal:  Arch Neurol       Date:  1994-02

3.  The neuroimaging and clinical spectrum of neurofibromatosis 2.

Authors:  V F Mautner; M Lindenau; M E Baser; W Hazim; M Tatagiba; W Haase; M Samii; R Wais; S M Pulst
Journal:  Neurosurgery       Date:  1996-05       Impact factor: 4.654

4.  Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations.

Authors:  M E Baser; V F Mautner; N K Ragge; A Nechiporuk; V M Riccardi; J Klein; J Sainz; S M Pulst
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

5.  Spinal MR findings in neurofibromatosis types 1 and 2.

Authors:  J C Egelhoff; D J Bates; J S Ross; A D Rothner; B H Cohen
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jul-Aug       Impact factor: 3.825

6.  Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree.

Authors:  M Sainio; T Strachan; G Blomstedt; O Salonen; K Setälä; A Palotie; J Palo; I Pyykkö; L Peltonen; J Jääskeläinen
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

7.  Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers.

Authors:  M H Ruttledge; S A Narod; J P Dumanski; D M Parry; R Eldridge; W Wertelecki; J Parboosingh; M C Faucher; G M Lenoir; V P Collins
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

8.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08

9.  Diagnostic issues in a family with late onset type 2 neurofibromatosis.

Authors:  D G Evans; D Bourn; A Wallace; R T Ramsden; J D Mitchell; T Strachan
Journal:  J Med Genet       Date:  1995-06       Impact factor: 6.318

Review 10.  Neurofibromatosis 2 (bilateral acoustic neurofibromatosis).

Authors:  R L Martuza; R Eldridge
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

View more
  3 in total

1.  Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.

Authors:  Kristy Truong; Iram Ahmad; J Jason Clark; Alison Seline; Tyler Bertroche; Brian Mostaert; Douglas J Van Daele; Marlan R Hansen
Journal:  Neuroscience       Date:  2018-02-03       Impact factor: 3.590

2.  Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy.

Authors:  P Bäumer; V F Mautner; T Bäumer; M U Schuhmann; M Tatagiba; S Heiland; T Kaestel; M Bendszus; M Pham
Journal:  J Neurol       Date:  2012-07-04       Impact factor: 4.849

Review 3.  A neuronal function of the tumor suppressor protein merlin.

Authors:  Alexander Schulz; Ansgar Zoch; Helen Morrison
Journal:  Acta Neuropathol Commun       Date:  2014-07-12       Impact factor: 7.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.